Future immunologic therapies will, no doubt, be based on emergent evidence that tumor necrosis factor (TNF-alpha) is an important humoral mediator of KATP channel remodeling in cardiomyocyte hypertrophy and heart failure [32]. Here, TNF is linked to heart failure.